By Ahmed Allam

Cairo – Mubasher: Shareholders of Memphis Pharmaceutical and Chemical Industries (MPCI) endorsed on Tuesday the company’s financial statements for the fiscal year ended 30 June 2015.

They also ratified the board’s report on business activity, as well as financial statements for the same year.

The company’s unaudited adjusted financial statements for FY14/15 showed EGP 10.3 million loss, against EGP 14,000 net profit a year ago.